AAAAAA
Results:
1-18
|
Results: 18
Authors:
KRAUS MD
FERANDOZA M
GARCIAMOLINER ML
ANTIN J
ODZE RD
Citation: Md. Kraus et al., CYTOMEGALOVIRUS-INFECTION IN THE COLON OF BONE-MARROW TRANSPLANTATIONPATIENTS, Modern pathology, 11(1), 1998, pp. 29-36
Authors:
BOSWELL GW
BEKERSKY I
FAY J
WINGARD J
ANTIN J
WEISDORF D
MAHER R
FITZSIMMONS W
NASH R
Citation: Gw. Boswell et al., TACROLIMUS PHARMACOKINETICS IN BMT PATIENTS, Bone marrow transplantation, 21(1), 1998, pp. 23-28
Authors:
KRAUS MD
SHAHSAFAEI A
ANTIN J
ODZE RD
Citation: Md. Kraus et al., RELATIONSHIP OF BCL-2 EXPRESSION WITH APOPTOSIS AND PROLIFERATION IN COLONIC GRAFT-VERSUS-HOST DISEASE, Human pathology, 29(8), 1998, pp. 869-875
Authors:
PORTER D
SCHENKEIN D
RAUCH A
LONGTINE J
MILLER K
ANTIN J
Citation: D. Porter et al., UNUSUAL PATTERN OF RELAPSE AFTER DONOR LEUKOCYTE INFUSIONS (DLI) FOR RELAPSED CML - LACK OF GRAFT-V-LEUKEMIA (GVL) EFFECT FOR ISOLATED CHLOROMAS, Blood, 90(10), 1997, pp. 4473-4473
Authors:
WHEELER C
KHURSHID A
IBRAHIM J
ELIAS A
MAUCH P
ANTIN J
Citation: C. Wheeler et al., LOW INCIDENCE OF POSTTRANSPLANT MYELODYSPLASIA ACUTE-LEUKEMIA (MDS AML) IN NHL PATIENTS AUTOTRANSPLANTED AFTER AFTER CYCLOPHOSPHAMIDE, CARMUSTINE AND ETOPOSIDE (CBV)/, Blood, 90(10), 1997, pp. 4480-4480
Authors:
DAVIES SM
CONFER D
KOLLMAN C
ANASETTI C
ANTIN J
GAJEWSKI J
CASPER JT
NADEMANEE A
NOREEN H
KING R
KERNAN NA
Citation: Sm. Davies et al., ENGRAFTMENT OF UNRELATED DONOR BONE-MARROW - A REPORT FROM THE NATIONAL MARROW DONOR PROGRAM (NMDP), Blood, 90(10), 1997, pp. 1762-1762
Authors:
PORTER DL
COLLINS R
DROBYSKI W
CONNORS JM
VANHOEF M
ANTIN J
Citation: Dl. Porter et al., LONG-TERM FOLLOW-UP OF 55 PATIENTS WHO ACHIEVED COMPLETE REMISSION (CR) AFTER DONOR LEUKOCYTE INFUSIONS (DLI) FOR RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), Blood, 90(10), 1997, pp. 2444-2444
Authors:
NASH RA
ANTIN J
KARANES C
FAY J
AVALOS B
YEAGER AM
PRZEPIORKA D
DAVIES S
PETERSEN F
BUELL D
FITZSIMMONS W
BARTELS P
HANSEN J
ANASETTI C
STORB R
RATANATHARATHORN V
Citation: Ra. Nash et al., PHASE-III STUDY COMPARING TACROLIMUS (FK506) WITH CYCLOSPORINE (CSP) FOR PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER MARROWTRANSPLANTATION FROM UNRELATED DONORS, Blood, 90(10), 1997, pp. 2499-2499
Authors:
PORTER D
COLLINS R
MICK R
KERNAN N
GIRALT S
FLOWERS M
CASPER J
DROBYSKI W
LEAHEY A
PARKER P
BATES B
KING R
ANTIN J
Citation: D. Porter et al., UNRELATED DONOR LEUKOCYTE INFUSIONS (U-DLI) TO TREAT RELAPSE OR EBV-LYMPHOPROLIFERATIVE DISEASE (EBV-LPD) AFTER UNRELATED DONOR BONE-MARROWTRANSPLANTATION (BMT), Blood, 90(10), 1997, pp. 2622-2622
Authors:
WINSTON DJ
ANTIN J
WOLFF S
SMALL T
MILLER K
LINKER C
KAIZER H
LAZARUS H
PETERSEN F
BIERER B
COWAN M
HO W
WINGARD J
PETRARCA M
TONETTA S
Citation: Dj. Winston et al., COMPARARATIVE EFFICACY OF DIFFERENT DOSES OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER BONE-MARROW TRANSPLANTATION (BMT) - RESULTS OF A MULTICENTER, RANDOMIZED,DOUBLE-BLIND TRIAL, Blood, 88(10), 1996, pp. 1198-1198
Authors:
WOLFF S
WINSTON D
ANTIN J
SMALL T
MILLER K
LINKER C
KAIZER H
LAZARUS H
PETERSEN F
BIERER B
COWAN M
HO W
WINGARD J
PETRARCA M
TONETTA S
Citation: S. Wolff et al., MULTI CENTER RANDOMIZED DOUBLE-BLIND DOSE-RESPONSE TRIAL OF IVIG FOR THE PREVENTION OF INFECTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO-BMT), Blood, 88(10), 1996, pp. 1199-1199
Authors:
RICHARDSON P
KRISHNAN A
WHEELER C
HOPPENSTEADT D
TUCHIN J
FYFE H
BIERER B
GUINAN E
ANTIN J
FREI E
FAREED J
ELIAS A
Citation: P. Richardson et al., ELEVATION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 [PAI-1] LEVELS IN BMT-ASSOCIATED VENOOCCLUSIVE DISEASE [VOD] AND CHANGES SEEN WITH THE USE OF DEFIBROTIDE [DF], Blood, 88(10), 1996, pp. 1821-1821
Authors:
MCGLAVE P
KOLLMAN C
SHU XO
ANASETTI C
NADEMANEE A
CHAMPLIN R
ANTIN J
KERNAN N
KING R
Citation: P. Mcglave et al., THE FIRST 1000 UNRELATED DONOR TRANSPLANTS FOR CML - LESSONS FROM THENATIONAL MARROW DONOR PROGRAM (NMDP) EXPERIENCE, Blood, 88(10), 1996, pp. 1922-1922
Authors:
COLLINS R
SHPILBERG O
DROBYSKI W
PORTER D
ANTIN J
WOLFF S
GIRALT S
CHETRIT A
OGNOSKIE N
PRINE S
NEMUNAITIS J
Citation: R. Collins et al., DONOR LEUKOCYTE INFUSION (DLI) FOR POST-BONE MARROW TRANSPLANT (BMT) RELAPSE - RETROSPECTIVE COHORT ANALYSIS OF 141 CASES, Blood, 86(10), 1995, pp. 2241-2241
Authors:
PORTER D
ROTH M
MCGARIGLE C
LEE S
FERRARA J
ANTIN J
Citation: D. Porter et al., THE GRAFT-VS-LEUKEMIA (GVL) EFFECT OF DONOR MONONUCLEAR CELL (MNC) INFUSIONS FOR PATIENTS WITH RELAPSED ACUTE-LEUKEMIA AND MYELODYSPLASIA (MDS) AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), Blood, 84(10), 1994, pp. 10000338-10000338
Authors:
WHEELER C
STRAWDERMAN M
AYASH L
CHURCHILL WH
BIERER BE
ELIAS A
GILLILAND DG
ANTMAN K
GUINAN EC
EDER JP
WEINSTEIN H
SCHWARTZ G
FERRARA J
MAZANET R
RIMM IJ
TEPLER I
MCCARTHY P
MAUCH P
AULT K
GAYNES L
MCCAULEY M
SCHNIPPER LE
ANTIN J
Citation: C. Wheeler et al., PROGNOSTIC FACTORS FOR TREATMENT OUTCOME IN AUTOTRANSPLANTATION OF INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA WITH CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE, Journal of clinical oncology, 11(6), 1993, pp. 1085-1091
Authors:
ALOSCO SM
SALAZAR M
CHOPEK M
ANTIN J
RAPPEPORT J
YUNIS EJ
Citation: Sm. Alosco et al., HLA-DPB MISMATCHES IN MLR AND UNRELATED BONE-MARROW TRANSPLANTS, Human immunology, 37, 1993, pp. 82-82
Authors:
GUINAN E
PARSONS S
LONGTINE J
RYAN H
BIERER B
FERRARA J
GILLILAND G
RIMM I
BALLEN K
TARBELL N
NEUBERG D
BURAKOFF S
WEINSTEIN H
ANTIN J
Citation: E. Guinan et al., DIFFERENT TOXICITIES ASSOCIATED WITH 3 GVHD PROPHYLAXIS REGIMENS FOR UNRELATED DONOR BONE-MARROW TRANSPLANTATION (UDBMT), Blood, 82(10), 1993, pp. 10000421-10000421
Risultati:
1-18
|